Chesnara plc

LSE:CSN 주식 보고서

시가총액: UK£381.3m

Chesnara 미래 성장

Future 기준 확인 1/6

Chesnara is forecast to grow earnings at 11.8% per annum. EPS is expected to grow by 11.7% per annum.

주요 정보

11.8%

수익 성장률

11.7%

EPS 성장률

Insurance 수익 성장18.5%
매출 성장률n/a
향후 자기자본 수익률11.5%
애널리스트 커버리지

Low

마지막 업데이트11 Sep 2024

최근 미래 성장 업데이트

업데이트 없음

Recent updates

Chesnara's (LON:CSN) Dividend Will Be Increased To UK£0.15

Apr 03
Chesnara's (LON:CSN) Dividend Will Be Increased To UK£0.15

We Think Shareholders May Want To Consider A Review Of Chesnara plc's (LON:CSN) CEO Compensation Package

May 12
We Think Shareholders May Want To Consider A Review Of Chesnara plc's (LON:CSN) CEO Compensation Package

Is Chesnara plc (LON:CSN) A Strong Dividend Stock?

Mar 26
Is Chesnara plc (LON:CSN) A Strong Dividend Stock?

What Type Of Shareholders Make Up Chesnara plc's (LON:CSN) Share Registry?

Mar 04
What Type Of Shareholders Make Up Chesnara plc's (LON:CSN) Share Registry?

If You Had Bought Chesnara's (LON:CSN) Shares Three Years Ago You Would Be Down 30%

Feb 12
If You Had Bought Chesnara's (LON:CSN) Shares Three Years Ago You Would Be Down 30%

Chesnara plc (LON:CSN) On An Uptrend: Could Fundamentals Be Driving The Stock?

Jan 22
Chesnara plc (LON:CSN) On An Uptrend: Could Fundamentals Be Driving The Stock?

Are Dividend Investors Making A Mistake With Chesnara plc (LON:CSN)?

Dec 18
Are Dividend Investors Making A Mistake With Chesnara plc (LON:CSN)?

What Kind Of Shareholders Own Chesnara plc (LON:CSN)?

Nov 30
What Kind Of Shareholders Own Chesnara plc (LON:CSN)?

수익 및 매출 성장 예측

LSE:CSN - 애널리스트의 미래 추정치 및 과거 재무 데이터 (GBP Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
6/30/202441053838N/A
3/31/20243901211N/A
12/31/202337019-36-35N/A
9/30/202335315-60-59N/A
6/30/202333813-49-46N/A
3/31/2023290-10-47-44N/A
12/31/2022241-34-45-42N/A
9/30/2022506-28-40-37N/A
6/30/2022771-22-35-31N/A
3/31/20221,1353-6-2N/A
12/31/20211,500272327N/A
9/30/20211,57137-23-23N/A
6/30/20211,64146-68-73N/A
3/31/20211,13733-7-10N/A
12/31/2020633215452N/A
9/30/2020500206162N/A
6/30/2020366186772N/A
3/31/202090449813N/A
12/31/20191,44279-50-47N/A
9/30/20191,01468-3-1N/A
6/30/2019586574446N/A
3/31/2019304405153N/A
12/31/201823245961N/A
9/30/2018407393638N/A
6/30/2018791531415N/A
3/31/201881466N/A37N/A
12/31/201783778N/A60N/A
9/30/201784680N/A38N/A
6/30/201785482N/A16N/A
3/31/201776158N/A-22N/A
12/31/201666735N/A-60N/A
9/30/201644224N/A-32N/A
6/30/201621712N/A-5N/A
3/31/201625426N/A-2N/A
12/31/201529240N/A2N/A
9/30/201542635N/A4N/A
6/30/201556131N/A7N/A
3/31/201557328N/A31N/A
12/31/201458626N/A56N/A
9/30/201464340N/A43N/A
6/30/201470055N/A31N/A
3/31/201471852N/A-1N/A
12/31/201373649N/A-33N/A

애널리스트 미래 성장 예측

수입 대 저축률: CSN's forecast earnings growth (11.8% per year) is above the savings rate (1.9%).

수익 vs 시장: CSN's earnings (11.8% per year) are forecast to grow slower than the UK market (14.4% per year).

고성장 수익: CSN's earnings are forecast to grow, but not significantly.

수익 대 시장: Insufficient data to determine if CSN's revenue is forecast to grow faster than the UK market.

고성장 수익: Insufficient data to determine if CSN's revenue is forecast to grow faster than 20% per year.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: CSN's Return on Equity is forecast to be low in 3 years time (11.5%).


성장 기업 발견